Bromocriptine and lisuride in Parkinson disease-Reference-Cited by-同舟云学术

Bromocriptine and lisuride in Parkinson disease

Published:1983-01 Issue:1 Volume:13 Page:44-47
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Lieberman Abraham N.,Gopinathan Govindan,Neophytides Andreas,Leibowitz Morton,Walker Russell,Hiesiger Emil

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference16 articles.

1. Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations

2. LONG-TERM TREATMENT OF PARKINSONISM WITH BROMOCRIPTINE

3. l-DOPA treatment in Parkinson's disease: Effect on dopamine and related substances in discrete brain regions

4. : The interactions of ergot compounds with dopamine agonist and dopamine antagonist receptors. In (eds): Ergot Compounds and Brain Function: Neuroendocrine and Neuropsychiatric Aspects. New York, Raven, 1980, pp 75-82

5. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson’s Disease;Current Neuropharmacology;2023-05

2. Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis;Journal of Medicinal Chemistry;2018-07-10

3. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor;Psychopharmacology;2009-11-25

4. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias;Parkinsonism & Related Disorders;2005-09

5. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism;European Journal of Nuclear Medicine and Molecular Imaging;1999-02-05